By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

"Many cases of OSA go undiagnosed ... of obstructive sleep apnea with obesity," researchers wrote in the New England Journal ...

“We think, in this specific case of sleep apnea, that increased size means increased swelling, because of inflammation or overall damage,” Ramos explained. Lower sleep oxygen levels linked to ...

Sleep apnea disrupts breathing during sleep ... Once diagnosed, OSA treatment varies based on severity. For mild-to-moderate cases, mandibular or dental devices are becoming increasingly common.

Snoring can be a sign of hypothyroidism, as low thyroid hormone levels may weaken respiratory muscles, contributing to airway ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

Wearables continued to rise in popularity this year, with Apple's devices proving to be lifesaving in these harrowing true ...

"Today, many cases of OSA go undiagnosed and untreated ... of participants treated with Zepbound achieved remission or mild sleep apnea with resolution of symptoms compared to placebo.

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight ... and brain problems."Many cases of OSA go undiagnosed and ...